Â鶹ֱ²¥ & Lardner LLP served as legal advisor to SkinCure Oncology, the world leader in providing a comprehensive model for the delivery of Image-Guided Superficial Radiation Therapy (Image-Guided SRT) in its recapitalization by an affiliate of leading global alternative investment firm H.I.G. Capital.
SkinCure Oncology partners with quality-focused dermatologists, Mohs surgeons, and other physicians to bring cancer center-level radiation therapy treatment to dermatology practices. Presented to patients as The GentleCureâ„¢ Experience, Image-Guided SRT – the most advanced nonsurgical treatment for common skin cancer – is available from some 500 physicians nationwide, with more than 100,000 patients having been treated. SkinCure Oncology’s current leadership team will remain in place and have a significant ownership stake in the recapitalized business.
The Â鶹ֱ²¥ team was led by partners Roger Strode, Steven Gerenraich, and John Palmer, who were assisted by partners Gregory Neppl and Leigh Riley with support from associates Daniel Costandy, Richard Flannery, and Michael Watkins.
